Podcasts about Esophageal

Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Vivek Kaul, MD The American Society for Gastrointestinal Endoscopy (ASGE) recently released a new guideline on when to use endoscopic submucosal dissection (ESD) and endoscopic mucosal resection (EMR) in managing early esophageal and gastric cancers. To learn more about when to use each approach, Dr. Peter Buch sits down with guideline co-author Dr. Vivek Kaul. Dr. Kaul is also the Segal-Watson Professor of Medicine at the University of Rochester Medical Center in New York.

In this episode of the Becker's Healthcare Podcast, Dr. John Hunter, former CEO of OHSU and expert esophageal surgeon, discusses the evolving dynamics between healthcare executives and physicians in a post-pandemic world. From the rise of physician unionization to fostering sustainable work environments and aligning missions, Dr. Hunter shares valuable insights and advice for healthcare leaders striving to create meaningful change in their organizations and communities.

In this episode of Thinking Thoracic, Dr. Jane Yanagawa talks with Dr. Stephanie Worrell, clinical associate professor and thoracic section chief, division of cardiothoracic surgery, University of Arizona, about her expertise in esophageal perforation management. Hear how esophageal surgery can involve complications such as anastomotic leak, pain, bleeding, infection, and reflux and how surgeons can best handle them. 

The dreaded esophageal injury.  Do you still have nightmares about mock oral board scenarios torturing you with the ins and outs of how to manage traumatic esophageal injury?  Think you remember all the nuances?  Whether you do or you don't, this episode should serve as a good refresher for all levels while offering some pearls for management of this tricky scenario. Hosts: - Michael Cobler-Lichter, MD, PGY4/R2: University of Miami/Jackson Memorial Hospital/Ryder Trauma Center @mdcobler (X/twitter) - Dylan Tanzer, MD, 2nd-year Trauma/Surgical Critical Care Fellow University of Miami/Jackson Memorial Hospital/Ryder Trauma Center - Eugenia Kwon, MD, Trauma/Surgical Critical Care Attending: Loma Linda University Recent graduate of University of Miami/Jackson Memorial Hospital/Ryder Trauma Center Trauma/CC Fellowship - Jonathan Meizoso, MD, MSPH Assistant Professor of Surgery, 5 years in practice University of Miami/Jackson Memorial Hospital/Ryder Trauma Center @jpmeizoso (twitter) Learning Objectives: - Describe the diagnostic workup of a suspected traumatic esophageal injury - Identify when someone with suspected esophageal injury needs immediate surgical management - Describe appropriate surgical techniques for repair of both cervical and thoracic esophageal injuries Quick Hits: 1.     Don't forget the primary survey.  Unstable patients should be in the OR, as should patients with hard signs of vascular or aerodigestive injury 2.     If there is concern for esophageal injury but no immediate indication for the OR, this should be further investigated with CTA of the affected area.  Clinical exam has poor sensitivity. 3.     The esophagus should be primarily repaired if the defect is able to come together without tension after debridement.  Don't forget a well-vascularized buttress 4.     If you cannot perform a primary repair, your procedure of choice should be lateral esophagostomy with feeding jejunostomy and gastrostomy for decompression.  Repair over T-tube can be considered for injuries with small amounts of tissue loss References 1.     Biffl WL, Moore EE, Feliciano DV, Albrecht RA, Croce M, Karmy-Jones R, et al. Western Trauma Association Critical Decisions in Trauma: Diagnosis and Management of Esophageal Injuries. J Trauma Acute Care Surg 2015;79(6):1089-95. https://pubmed.ncbi.nlm.nih.gov/26680145/ 2.     Sperry JL, Moore EE, Coimbra R, Croce M, Davis JW, Karmy-Jones R, et al. Western Trauma Association Critical Decisions in Trauma: Penetrating Neck Trauma. J Trauma Acute Care Surg 2013;75(6):936-40. https://pubmed.ncbi.nlm.nih.gov/24256663/ Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.   If you liked this episode, check out our recent episodes here: https://app.behindtheknife.org/listen

Behind the Knife es el podcast quirúrgico líder en el mundo y una plataforma de educación quirúrgica. Nuestra misión es crear contenido innovador de educación quirúrgica que sea accesible para todos. Estamos muy emocionados de expandirnos al público hispanohablante y ofrecerles 4 episodios de muestra de nuestro Curso de Repaso para el examen de certificación de Cirugía General. Hoy, escucharás un caso de muestra de este curso de repaso en audio, que incluye 100 escenarios.  El curso tiene un formato emocionante y completamente único. Cada uno de los 100 caso consta de dos partes. La primera parte es un caso oral perfectamente ejecutado que imita la realidad. Cada caso tiene una duración de cinco a siete minutos e incluye una variedad de tácticas y estilos. Si logras alcanzar este nivel de desempeño en tu preparación, seguramente aprobarás el examen de certificación con éxito. La segunda parte introduce comentarios de alto rendimiento para cada escenario. Estos comentarios incluyen consejos y trucos para ayudarte a dominar los escenarios más desafiantes, además de una enseñanza práctica y fácil de entender que cubre los temas más confusos que enfrentamos como cirujanos generales. Estamos seguros de que encontrarás este enfoque único de doble formato como una forma altamente efectiva de prepararte para el examen. Nuestro contenido está disponible en nuestras aplicaciones para iOS y Android y en nuestro sitio web (behindtheknife.org). Por favor, consulta las notas del programa para más información. Nos encantaría escuchar tus comentarios sobre este episodio enviando un correo electrónico a hello@behindtheknife.org y apreciamos tu ayuda para difundir la palabra entre tus colegas si disfrutas del material. Si los comentarios son positivos, traduciremos todo nuestro curso al español.  presentadores de podcast: - Auri P. Garcia Gonzalez, MD PhD nació en San Juan, Puerto Rico, y se trasladó a los Estados Unidos en el 2012 para sus estudios graduados. Actualmente, es estudiante de post-grado en cirugía general en Duke University.  - Diego Schaps, MD, MPH es un residente de cirugía general en Duke y nació en Miami, en el estado de la Florida. Sus padres nacieron en El Salvador. Disclaimer: Los productos de contenido de Behind the Knife son únicamente para fines educativos. No diagnosticamos, tratamos ni ofrecemos consejos específicos para pacientes. ------ Behind the Knife is the world's leading surgical podcast and surgical education platform.  Our mission is to create innovative surgical education content that is accessible to all.  We are very excited to expand into the spanish audience and bring you 4 sample episodes of our General Surgery Oral Board Review Course which will be released over the course of the next week. Today, you'll hear a sample scenario from this comprehensive audio review course which includes 100 scenarios.  The course has an exciting and entirely unique format. Each of the 100 scenarios includes two parts. The first part is a perfectly executed oral board scenario that mimics the real thing. Scenarios are five to seven minutes long and include a variety of tactics and styles. If you're able to achieve this level of performance in your preparation, you are sure to pass the oral exam with flying colors.    The second part introduces high yield commentary to each scenario. This commentary includes tips and tricks to help you dominate the most challenging scenarios in addition to practical, easy to understand teaching that covers the most confusing topics that we face as general surgeons. We are confident you will find this unique dual format approach a highly effective way to prepare for the test. Our content is available on our iOS and Android apps and website (behindtheknife.org).  Please check the show notes for more information. We would love to hear your feedback by emailing hello@behindtheknife.org and appreciate your help spreading the word to your colleagues if you enjoy the material.  If feedback is positive, we will translate our entire course to Spanish.   Hosts: - Auri P. Garcia Gonzalez, MD PhD was born and raised in San Juan, Puerto Rico and moved to the US in 2012 for graduate studies. At present, she is a surgical resident at Duke University. - Diego Schaps, MD, MPH is a general surgery resident at Duke and was born in Miami, Florida. His parents were born in El Salvador. Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.   If you liked this episode, check out our recent episodes here: https://app.behindtheknife.org/listen

Dr. Lisa Mathew interviews Dr. Raman Muthusamy, professor of clinical medicine at the David Geffen School of Medicine at UCLA, and medical director of endoscopy for UCLA Health, about a new clinical guideline for endoscopic eradication therapy to prevent the progression of Barrett's esophagus to esophageal cancer. Esophageal cancer is preventable if high-risk patients, such as those with Barrett's Esophagus, are treated with endoscopic eradication therapy to eliminate the Barrett's tissue. Endoscopic eradication therapy is highly effective, but the challenge is identifying the high-risk patients to treat and the low-risk patients for whom long-interval surveillance may be appropriate. Join Dr. Mathew and Dr. Muthusamy as they explore new technologies for identifying patients who are most at risk and the potential innovations that could stop a majority of Barrett's Esophagus patients from progressing to esophageal cancer. Produced by Andrew Sousa and Hayden Margolis for Steadfast Collaborative, LLC Mixed and mastered by Hayden Margolis Gastro Broadcast, Episode 65

We delve into the management of esophageal foreign body obstructions, a common yet often misunderstood medical emergency. We discuss the symptoms and causes of esophageal food impactions, sometimes referred to as 'Steakhouse Syndrome,' and differentiate it from tracheal obstructions. We explore the protocols, potential treatments, and if there's any rationale behind treatments such as glucagon administration. Join us as we also share real-life scenarios to better illustrate the challenges and solutions when dealing with such medical cases.   Resources and links This episode was inspired by an article on EMSAirway.com- Friday Night Lights- Shift 9 Steak Night  EMScast15 - code for 15% off an awesome pair of sunglasses  Help Us By Filling Out Our Audience Survey  Medic Box - awesome medical gear shipped directly to your door  Articles- American Society for Gastrointestinal Endoscopy- Guidelines for ingested foreign bodies   Glucagon for Relief of Acute Esophageal Foreign Bodies and Food Impactions: A Systematic Review and Meta-Analysis.   Efficacy of cola ingestion for oesophageal food bolus impaction: open label, multicentre, randomised controlled trial   Conservative management of oesophageal soft food bolus impaction   Esophageal Food Impaction: A Retrospective Chart Review Food Bolus Impaction- Question and Answer Review     Guest/Cast/Crew information- Host- Ross Orpet, Will Berry    Catch up with us after the show Instagram- @emscast Twitter- @ems_cast Website- www.emspodcast.com   00:00 Introduction to Esophageal Foreign Bodies 00:43 Audience Survey and Sunglasses Giveaway 01:46 Interview with Contest Winner 06:11 A Choking Incident at Mile High Stadium 09:02 Discussion on Esophageal Obstructions 11:46 Life-Saving Story at Denver International Airport 13:28 A Life-Saving Outcome 14:11 The Choking Incident at the Tavern 14:57 Assessing the Patient's Condition 19:38 Understanding Esophageal Food Impaction 21:49 Treatment Options and Challenges 29:01 The Role of Endoscopy 37:45 Managing Esophageal Impactions in the Field 39:32 Final Thoughts

Esophageal pressure measurement plays a crucial role in estimating transpulmonary pressure, with both its absolute values and variations being key factors in assessing lung injury from mechanical forces during ventilation. To gain deeper insights into esophageal pressure monitoring and the essential equipment required for accurate measurement, tune in to the NEXT podcast. Luigi Zattera, the NEXT representative, conducted an insightful interview with Lise Piquilloud, head of the Acute Respiratory Failure (ARF) section.

In early 2020, it became difficult for Clinton to eat. It was during the pandemicand much harder at the time to see a doctor, so it took a while before he was able to get checked out. In January 2021, Clinton was diagnosed with esophageal cancer that metastasized into his lungs. His treatment included six months on a feeding tube, chemotherapy and radiationtreatments. In summer 2021, he received an esophagectomy and now comes in forchemotherapy every other week. He will continue these sessions for the foreseeablefuture. The American Cancer Society estimates that there will be about 22,370 newesophageal cancer cases diagnosed (17,690 in men and 4,680 in women) in 2024. Esophageal cancer is more common among men than among women. Thelifetime risk of esophageal cancer in the United States is about 1 in 127 in men andabout 1 in 434 in women.

We welcome back Matthew Puc, MD, a thoracic surgeon for Virtua Hospital System, to discuss the incredibly serious and unusual injury which ended Dustin May's season. We also dabble in another weird "injury", Christian Barmore, a good young defensive tackle for the Patriots also had his season end, before it began, just after signing a huge contract because of blood clots...

Episode 174: GERD in AdultsCommon and atypical symptoms are presented. Pathophysiology, diagnosis, and management are discussed. H. pylori's role is discussed during this episode. Written by Jacquelyn Garcia MS4 Ross University School of Medicine. Comments by Hector Arreaza, MD.You are listening to Rio Bravo qWeek Podcast, your weekly dose of knowledge brought to you by the Rio Bravo Family Medicine Residency Program from Bakersfield, California, a UCLA-affiliated program sponsored by Clinica Sierra Vista, Let Us Be Your Healthcare Home. This podcast was created for educational purposes only. Visit your primary care provider for additional medical advice.Definitions: Gastroesophageal reflux (GER): occasional backflow of stomach acid into the esophagus. It's a common physiological process that happens to many people, especially after meals. Occurs less than twice a week. Associated with mild and temporary symptoms such as heartburn or regurgitation. Gastroesophageal reflux disease (GERD): a chronic and more severe form of GER. It occurs when acid reflux happens frequently, typically more than twice a week, and/or causes esophageal injury/complications. -Non-erosive reflux disease (NERD)= GER without evidence of esophageal injury on endoscopy. -Erosive reflux disease (ERD)= GER with evidence of esophageal injury on endoscopy.AFP Journal, January 2024: “Nonerosive GERD does not increase the likelihood of esophageal cancer. However, erosive GERD is associated with a doubled, but still low, risk of developing cancer, with the likelihood increasing over time.”Pathophysiology:The main pathophysiology behind GERD is lower esophageal sphincter (LES) dysfunction which can occur due to the following:-LES Pressure: The LES is a muscular ring at the junction of the esophagus and stomach. It normally maintains a high-pressure zone to prevent reflux. In GERD, the intragastric pressure is higher than the pressure created by the LES. The tone of the LES can be reduced by caffeine, nitroglycerin, and scleroderma. -Transient LES Relaxations (TLESRs): These are normal relaxations of the LES that occur independently of swallowing. In GERD, these relaxations are more frequent or prolonged, allowing acid to reflux into the esophagus.-Anatomic abnormalities: A hiatal hernia occurs when a portion of the stomach protrudes through the diaphragm into the chest cavity. This disrupts the normal anatomy of the gastroesophageal junction, reducing the pressure barrier and promoting reflux.Epidemiology: It affects 10-20% of adults in Western cultures and less than 5% in Asia. Prevalence in the US ranges from 18.1% to 27.8% with a slightly higher rate in men. Risk factors: -Obesity, pregnancy, scleroderma, hiatal hernia; smoking, caffeine, alcohol, stress, fatty/fried/spicy foods. Spicy foods can be a challenge in some cultures (e.g. Mexican and Indian.) Sometimes, patients may ask for “something” to stop GERD but all they may need is dietary modification. -Medications: -aspirin, ibuprofen, clindamycin, tetracycline, bisphosphonates (irritate the esophagus and cause heartburn pain similar to GERD) -anticholinergics, TCA's, CCB's, ACEi, statins, benzodiazepines, theophylline, opioids, progesterone (increase acid reflux and worsen GERD)Clinical features: Typical symptoms: -heartburn (burning retrosternal pain) -regurgitation (acidic stomach contents)Atypical symptoms: -chest pain (can mimic angina pectoris, squeezing/burning substernal, radiates to back/neck/jaw/arm) -water brash (hypersalivation)-globus sensation (lump in throat)-nausea -belching-bloating Alarm features in GERD: -dysphagia-odynophagia (pain with swallowing)-new onset of dyspepsia in ≥60yo -weight loss-GI bleeding-vomiting-anemia Diagnosis: -There is no gold standard test -Patient with typical symptoms: diagnosis can be based on clinical symptoms alone -Patient with atypical symptoms: these symptoms can be seen in GERD but are not sufficient for diagnosis of GERD in the absence of typical symptoms. Need to rule out other disorders before associating the symptoms with GERD. (ex: chest pain r/o other causes such as MI with ECG) -Patient with alarm features: refer to GI for upper GI endoscopy. Complications: -Esophagitis: Erosive reflux disease (ERD) = GER with evidence of esophageal distal injury on endoscopy; in untreated GERD 30% have esophagitis. -Iron deficiency anemia: due to mucosal ulcerations -> chronic bleeding.-Esophageal stricture: narrowing near GE junction, solid food dysphagia.-Barrett Esophagus: intestinal metaplasia of esophagus due to chronic GERD (stratified squamous epithelium replaced by columnar epithelium)-Risk factors: GERD for 5-10 years, >50yo, males, obesity, Caucasian, Tobacco use, family history                 -Predisposes to esophageal adenocarcinoma Role of H. pylori.Sometimes we tend to think that H. pylori is the cause of GERD. “H. pylori infection appears to protect the esophagus from gastroesophageal reflux disease, Barrett's esophagus, dysplasia in Barrett's esophagus, and esophageal adenocarcinoma, perhaps by causing chronic gastritis that interferes with acid production.”It is unclear whether long-term use of PPIs heightens the risk of atrophic gastritis in patients with H. pylori. Consequently, routine screening for H. pylori infection and empiric eradication of H. pylori are NOT advised for patients with GERD. However, if H. pylori is diagnosed in the setting of GERD, eradication of H. pylori has been associated with an improvement of symptoms in patients with antral-predominant gastritis. Treatment: Two categories: Mild/intermittent symptoms (

CME credits: 1.00 Valid until: 17-07-2025 Claim your CME credit at https://reachmd.com/programs/cme/case-consult-treatment-options-for-an-unresectable-hcc-patient-who-has-esophageal-varices/26335/ This online MinuteCE program provides a comprehensive evaluation of the latest clinical data on first-line immune checkpoint inhibitor (ICI) combinations for the treatment of unresectable hepatocellular carcinoma (HCC). Participants will critically assess survival outcomes and other key efficacy metrics from recent studies. The program emphasizes the application of efficacy and safety data to tailor treatment regimens based on individual patient profiles and preferences. Additionally, it addresses the recognition and management of treatment-related adverse events associated with these regimens. The course also incorporates strategies for effective communication and shared decision-making within the multidisciplinary care team, ensuring optimal patient-centered care.

Gastric (stomach) and esophageal cancers are common malignancies that affect the first parts of the digestive tract. About 50,000 new cases of gastric and esophageal cancer will be diagnosed each year in the United States. In this episode of the All In Against Cancer podcast, gastrointestinal medical oncologist Dr. Jonathan Mizrahi talks with Ochsner surgical oncologist, Dr. Nathan Bolton, and surgical oncology nurse practitioner, Jessica Pride, to learn more about the diagnosis, staging and management of patients with gastroesophageal cancers.

Treatment with perioperative chemotherapy, with chemotherapy before and after surgery, brought superior outcomes for patients with locally advanced esophageal adenocarcinoma, in research reported to the 2024 ASCO Annual Meeting. Lead author Jens Höppner FAChirg, FACS, MD, Director of the Department of Surgery in the University Medical Center at the University of Bielefeld in Germany, spoke with Oncology Times reporter Peter Goodwin about his group’s comparison of neoadjuvant therapy using the CROSS (41.4 Gy plus carboplatin/paclitaxel) regimen followed by surgery, with the use of an alternative protocol: perioperative FLOT (5-FU/ leucovorin/oxaliplatin/docetaxel) and surgery, in which chemotherapy is given both before and after curative surgery.

A cirrhosis patient has stable vitals, but then starts vomiting blood. What do you do next? This episode delves into a case study that highlights the urgent management of esophageal varices in liver failure patients. Host Sarah Lorenzini reveals how a rapid response call quickly spiraled into a life-threatening emergency, and the critical steps taken to stabilize the patient.Sarah explains the pathophysiology of cirrhosis and the development of esophageal varices, detailing the pharmacological and procedural interventions that can make the difference between life and death. You'll get a comprehensive overview of evidence-based treatment strategies, how to manage complications, and the crucial role of nurses in patient care.Tune in to arm yourself with the knowledge to handle this critical liver emergency!Topics discussed in this episode:Management of a cirrhosis patient with a GI bleed How liver failure can lead to a bleeding esophagusChallenges of giving blood transfusions to liver failure patientsPharmacological interventions: octreotide, antibiotics, and beta-blockersProcedural interventions: endoscopic variceal ligation, TIPS procedure, and balloon tamponadeListen to Episode 77, “The Trauma, Diamond of Death:” https://podcasts.apple.com/us/podcast/77-the-trauma-diamond-of-death-4-treatment-priorities/id1535997752?i=1000633582257To learn more about balloon tamponade, check out this breakdown of the procedure: https://first10em.com/balloon-tamponade-of-massive-gi-bleeding/Mentioned in this episode:Rapid Response and Rescue Intro CourseCONNECT

Rick Greene, MD, discusses with Lorenzo Ferri, MD, PhD, the long-term survival outcomes of patients with esophageal and junctional adenocarcinoma treated with neoadjuvant docetaxel-based chemotherapy and en bloc transthoracic esophagectomy. Dr. Ferri is author of, "Docetaxel-Based Neoadjuvant Chemotherapy Followed by En Bloc Resection for Esophageal Adenocarcinoma: A 15-Year Retrospective Analysis from a Regional Upper Gastrointestinal Cancer Network." Dr. Ferri is Professor of Surgery and Oncology, McGill University; David S. Mulder Chair of Surgery Head, Division of Thoracic and Upper Gastrointestinal Surgery, McGill University Health Centre; and, Director, Upper G.I. Cancer Program, McGill University, Montreal, Canada.

In this episode of Empowering Plans, The Phia Group's CLO – Ron Peck – sits down with experienced surgeon, Dr. Victoria Lee, to discuss a very dangerous – and costly – threat.  Esophageal cancer is generally considered to be a death sentence, and historically screening options are invasive and costly, resulting in a low uptake.  With the introduction of EsoGuard, however, plans can identify which participants are at risk, and have them tested quickly, non-invasively, and inexpensively.  You can save lives and money… but you cannot afford to miss this episode.  For those interested in learning more about EsoGuard, please contact Jim Fricchione, Vice President – Employer Markets with Lucid Diagnostics, at 617-921-7949 or JMF@LucidDX.com.

Join us as we welcome the newest JAAPA podcast team member, Joe Harrison. Kim and Martine discuss Joe's background, interests, and why he joined the podcast. They also discuss their “why” of medicine and “why PA”. Finally, they discuss and summarize an important article by PA Daniel Eisner on esophageal cancers from the April 2024 JAAPA issue. Be sure to follow JAAPA on social media! Their Instagram handle is @jaapaonline. 

In this episode, we review the high-yield topic of⁠ ⁠⁠⁠⁠Esophageal Motility⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠from the Gastrointestinal section. Follow ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Medbullets⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ on social media: Facebook: www.facebook.com/medbullets Instagram: www.instagram.com/medbulletsofficial Twitter: www.twitter.com/medbullets --- Send in a voice message: https://podcasters.spotify.com/pod/show/medbulletsstep1/message

This week, Dr. Prather answers a common misconception about Iodine and Breast Cancer.  In this episode, you'll discover:—The extensive research showing how Low Iodine causes an increased chance of Breast Cancer and a faster growth in the Cancer.—Why the widespread belief of the medical profession that Iodine is dangerous is actually based upon a falsified study, which was paid for by the pharmaceutical companies and took 5 decades to debunk.—How Iodine used to be the most commonly prescribed medicine out there until the falsified study was published in 1948.  And the useful rhyme doctors used to quote about the importance of giving Iodine to patients.—Why Dr. Prather says that, "if you want good looking breasts then make sure your Iodine stays at a good level".  And how Iodine is important for the skin and has an anti-aging effect. —How Dr. Prather finds that 100% of patients in Indiana have Low Iodine.  And how Dr. Prather's office tests to make sure which form of Iodine will work best for your body.—How Iodine is "one of the most important things for any issue with the Breast", including Fibrocystic Breasts, preventing Breast Cancer, and improving the outcome of Breast Cancer.—The importance of Iodine in balancing our Hormones for optimal health.  And the link between a Hypothyroid (Low Functioning Thyroid) and Breast Cancer.—The Cancers that Iodine has been proven to help with, including: Breast, Stomach, Esophageal, Cervical, Ovarian, and Uterine Cancers.  And how Iodine helps prevent Cancer cells from replicating.—The benefits of Iodine for Men's health, including boosting Testosterone and being helpful with Prostate Cancer.  And the reason Selenium and the Zinc-Copper ratio are important considerations for Iodine to work properly in the body.—Why the Iodine levels of a breastfeeding Mom "makes a huge difference" for their child's I.Q.  And how proper Iodine levels can make your child bigger, stronger, healthier, and smarter.http://www.TheVoiceOfHealthRadio.com

Sales Meetings with Purpose. Lisa Thal is an Author, Inspirational Speaker, and Business Coach with over 37 years of marketing, sales, and leadership experience. She wrote the book Three Word Meetings. Lisa coaches leaders on creating sales and business meetings with fun and interesting 3-word topics that spark conversation and inspire sales teams.   Episode 236, How your Attitude, Discipline, and Determination can make a difference in your business, relationships, and Health!   I would like to ask you a question on a scale of 1-10: How is your Attitude today? What do you think about your Discipline and determination? Take the time to assess your health, relationships, and business.    Looking back over the past six months, I see it has been a journey. My wife Olivia, during an endoscope, was diagnosed with esophageal cancer. For those who have not met Olivia, she is very active with Mountain Biking and hiking our Pups, eats healthy, and doesn't drink or smoke.    So when the doctor came in and shared that he was sure she had Esophageal cancer, we were a bit in shock. Looking back over the past six months, I feel that what made the difference in Olivia beating cancer was her Attitude, Discipline, and Determination in this challenging situation. And the Team of doctors at the Barrett Center at the University of Cincinnati.     Liv had to mentally prepare for what she was about to face physically. Rounds of Chemo, 28 days of radiations on her throat, which would make it challenging to swallow, and a significant 7-8 hour esophagectomy surgery.   Her Attitude was that she would fight through each situation, understanding that she would experience significant pain, but she had to keep moving forward. She was fighting for her life!   In addition to Liv's Attitude, I am most proud of her Discipline, whether it was how she would eat enough calories and protein in a day or even an hour when she couldn't swallow, her determination to walk our pups two miles after chemo treatments when mentally and physically challenged, or her determination to get up out of bed when in the ICU after a grueling 7-8-hour surgery. Liv is healing from surgery and is as determined as ever to return to her Mountain Bike.   Why am I sharing this story with you? Liv's story will inspire you to examine your health, relationships, and business.    Attitude, Discipline, and determination are three words that can fuel your success, and they are all in your control.    Why an Unwavering Attitude is Your Greatest Asset in Life and Business.   3 Tips to Unlocking Unprecedented Success:       Set Clear Goals and Stick to Your Plan The first step on the path of Discipline is setting clear goals. It is where you take control of your life, defining success in concrete terms and devising a systematic plan to achieve these goals. It involves focusing and holding yourself accountable to your daily schedule and tasks, which could include making a specific number of calls, personalizing follow-ups, or enhancing product knowledge. Remember, Discipline is choosing your long-term goals over short-term comfort in challenging times. This sense of control and capability fuels your determination and drives you towards success.     Develop Consistent Habits and Routines The power of routine is critical. Consistently following a structured day allows for efficiency and effectiveness in your sales strategy. Determination shows when you maintain client outreach, manage your CRM diligently, and practice your pitch or playbook even when leads are not converting as expected. Determination is the persistence through the mundane, trusting the process even when immediate results are not evident.     Learn, Adapt, and Overcome Setbacks  Your Discipline and Determination can be the difference-maker during times of failure and setbacks. In sales, rejection is a common occurrence. Approach each 'no' as an opportunity to learn and refine your approach. No, it means Not Yet. Stay determined to persist despite rejection, and be disciplined in analyzing your strategies, adapting to feedback, and improving your techniques. The real test of determination comes when you don't give up at the first sign of difficulty but rather see it as a stepping stone to eventual success. This resilience and determination sets you apart and keeps you moving forward.   Remember, Discipline is the foundation of sustained effort, and determination is the thrust that propels you forward amidst challenges. Attitude is Everything! How you approach each situation with I can, versus I won't will have you feeling more in control. In the competitive sales world, these qualities are beneficial and essential. They can create an unstoppable force in your sales career and personal accomplishments.   Do me a favor if someone can benefit from today's episode Share. If there is a topic you would like me to discuss, private message me.    Create engaging sales meetings in minutes!  My easy-to-use process can quickly create impactful meetings tailored to your Team's needs.    Learn more at www.Threewordmeetings.com.

In this episode, hosts Drs. Peter Lu and Jennifer Lee talk to Dr. Michael Wilsey about the evaluation and management of esophageal strictures in children, including congenital strictures and those arising from eosinophilic esophagitis and caustic ingestions. Dr. Wilsey is an advanced endoscopist at Johns Hopkins All Children's Hospital in St. Petersburg, FL and is a Professor at the University of South Florida.Learning Objectives:Review the presentation, evaluation, and management of congenital esophageal strictures.Understand the diagnostic tools used in the evaluation of an esophageal stricture, including the utility of functional luminal imaging probe (FLIP) testing.Understand the treatment options used for esophageal strictures, including the different types of dilation and the role of steroid injections and stenting.Links:Laughrey M, Kidder M, Rivera D, Wilsey M, Karjoo S. Development of an esophageal stricture following paradichlorobenzene mothball ingestion. SAGE Open Med Case Rep. 2020 Nov 13;8:2050313X20974210. PMID: 33240502 Support the showThis episode is eligible for CME credit! Once you have listened to the episode, click this link to claim your credit. Credit is available to NASPGHAN members (if you are not a member, you should probably sign up). And thank you to the NASPGHAN Professional Education Committee for their review!As always, the discussion, views, and recommendations in this podcast are the sole responsibility of the hosts and guests and are subject to change over time with advances in the field.Check out our merch website!Follow us on Twitter, Facebook and Instagram for all the latest news and upcoming episodes.Click here to support the show.

For Esophageal Cancer Awareness Month, Dr. Naresh Gunaratnam speaks with Dr. Srinadh Komanduri, associate chief of gastroenterology and hepatology and director of endoscopy at Northwestern Medicine, about efforts to educate the public about esophageal cancer and cutting-edge tools that are helping gastroenterologists determine which of their patients are at greatest risk of developing esophageal cancer. Esophageal cancer is preventable if high-risk patients, such as those with Barrett's Esophagus, are treated with endoscopic eradication therapy to eliminate the Barrett's tissue. Endoscopic eradication therapy is highly effective, but the challenge is identifying the high-risk patients to treat and the low-risk patients for whom long-interval surveillance may be appropriate. The Barrett's Esophagus surveillance program at Northwestern includes the TissueCypher test, which provides Dr. Komanduri and his colleagues with a personalized prediction of cancer progression risk based on molecular biomarkers that cannot be measured by traditional pathology. Join Dr. Gunaratnam and Dr. Komanduri to hear how gastroenterologists and pathologists can better identify patients who are most at-risk and provide the appropriate care to help prevent them from developing esophageal cancer. Produced by Andrew Sousa and Hayden Margolis for Steadfast Collaborative, LLC Mixed and mastered by Hayden Margolis Gastro Broadcast, Episode 56

Michael S. Lloyd, MD, FHRS, Emory University, is joined by guest Christopher R. Ellis, MD, FHRS, Vanderbilt Heart, and Stacy B. Westerman, MD, MPH, Emory University, to discuss Esophageal deviation devices for AF Ablation. https://www.hrsonline.org/education/TheLead https://www.jacc.org/doi/10.1016/j.jacep.2023.09.004#:~:text=The%20EASY%20AF%20trial%20(EsophAguS,esophageal%20lesions%20attributable%20to%20RFA Host Disclosure(s): M. Lloyd: Honoraria/Speaking/Consulting: Medtronic, Baylis Medical Company, Boston Scientific Contributor Disclosure(s): C. Ellis: Honoraria/Speaking/Consulting: Boston Scientific, Abbott Medical, Research: Medtronic, Boehringer Ingelheim S. Westerman: Honoraria/Speaking/Consulting: Boston Scientific  This episode has .25 ACE credits associated with it. If you want credit for listening to this episode, please visit the episode page on HRS365     https://www.heartrhythm365.org/URL/TheLeadEpisode57

Please visit nascentmc.com/podcast for all the details.  Go to learnAMAstyle.com for lots of freebies on AMA Style and the use of AI in medical writing and editing Here is information on the latest US FDA approvals, the week of March 11 – March 15, 2024 Liso-cel for CLL/SLL   - The FDA approved lisocabtagene maraleucel (liso-cel; Breyanzi) for adult patients with relapsed or refractory chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) who have received at least two prior therapies. It is a CAR T-cell therapy that modifies patient's T cells to target tumor antigens. The approval was based on the TRANSCEND CLL 004 study, showing a 20% complete response rate and a median duration of response not reached by the data cutoff. Tislelizumab for Esophageal SCC   - Tislelizumab-jsgr (Tevimbra) received FDA approval for unresectable or metastatic esophageal squamous cell carcinoma (ESCC) patients after prior systemic chemotherapy. The approval was based on the phase 3 RATIONALE 302 trial, which showed significant improvement in overall survival compared to chemotherapy (8.6 months vs. 6.3 months). This marks a critical advancement for patients with limited treatment options after first-line failures. Resmetirom for NASH   - The FDA approved resmetirom (Rezdiffra) for adults with non-cirrhotic non-alcoholic steatohepatitis (NASH) with moderate to advanced fibrosis, to be used alongside diet and exercise. This is the first medication approved to directly address liver damage in NASH patients with significant liver scarring, acting as a partial activator of a thyroid hormone receptor to reduce liver fat. The approval, based on a 54-month trial, used a surrogate endpoint at 12 months to demonstrate improvement in liver scarring and inflammation. Maralixibat for Cholestatic Pruritus   - Maralixibat (Livmarli) oral solution was approved for treating cholestatic pruritus in patients aged 5 years and older with progressive familial intrahepatic cholestasis (PFIC). It is an orally administered ileal bile acid transporter inhibitor, showing efficacy in the Phase 3 MARCH clinical trial across various genetic types of PFIC. Additionally, a higher concentration formulation is under consideration to extend its use to younger PFIC patients. Guselkumab for UC   - A supplemental Biologics License Application (sBLA) has been submitted for guselkumab (Tremfya) for treating adults with moderate-to-severely active ulcerative colitis (UC). The submission is based on the QUASAR program results, demonstrating significant clinical remission at Week 44 compared to placebo. Guselkumab, a novel IL-23 inhibitor, has previously been approved for moderate-to-severe plaque psoriasis and active psoriatic arthritis, marking its potential expansion into UC treatment.  

Download for FREE today -  special Mnemonics Cheatsheet - so you can be SURE that you have that Must Know information down:  bit.ly/nursing-memory   Outline The 3 C's C-Choking C-Coughing C-Cyanosis Description A tracheal esophageal fistula (TEF) is a congenital abnormality in which there is an opening between the trachea and the esophagus. Surgery is required to repair the opening before a baby can receive oral nutrition. Signs and symptoms to identify TEF are choking, coughing, and cyanosis.

Description: Co-host Ryan Piansky, a graduate student and patient advocate living with eosinophilic esophagitis (EoE) and eosinophilic asthma, and co-host Mary Jo Strobel, APFED's Executive Director, speak with Dr. Kathryn Peterson, MD, MSCI, a Professor of Gastroenterology at the University of Utah Health. In this episode, Ryan and Mary Jo interview Dr. Peterson about the family risk of eosinophilic gastrointestinal diseases, discussing the studies she has done, future work she is planning, and other studies of related topics. She shares that she is a parent to a patient living with an eosinophilic disorder. She hints at future research that may lead to easier diagnosis of EGIDs.   Listen in for more information on Dr. Peterson's work. Disclaimer: The information provided in this podcast is designed to support, not replace the relationship that exists between listeners and their healthcare providers. Opinions, information, and recommendations shared in this podcast are not a substitute for medical advice. Decisions related to medical care should be made with your healthcare provider. Opinions and views of guests and co-hosts are their own.   Key Takeaways: [:49] Ryan Piansky welcomes co-host Mary Jo Strobel. Mary Jo introduces Dr. Kathryn Peterson, a Professor of Gastroenterology at the University of Utah Health. Dr. Peterson specializes in diagnosing and treating diseases of the digestive system including eosinophilic esophagitis (EoE), Barrett's esophagus, and inflammatory bowel disease.   [2:00] Dr. Peterson works at the University of Utah in Salt Lake City. She co-directs an eosinophilic gastrointestinal disease clinic with Dr. Amiko Uchida. They also work closely with allergy, nutrition, and pharmacy in the clinic and are looking for additional ancillary services to come into the clinic.   [2:27] Dr. Peterson takes care of all sorts of eosinophilic gastrointestinal diseases. She works closely with Dr. Gerald Gleich, as well. Dr. Peterson is a mother of a boy living with eosinophilic disease for 10 years, so she experiences both sides of eosinophilic diseases. She loves her job.   [3:23] Familial risk refers to the risk of the disease in a patient when a family member is affected, compared to the general population. Looking at a proband (patient), is a first-degree family member (parent, sibling, or child) also affected with eosinophilic disease? Is a second-degree family member (grandparent) affected? Are cousins?   [3:58] Dr. Peterson's is trying to see if and how far out the risk for the disease goes within a family. Based on that, you can get an idea if some shared genes are involved, vs. shared environmental influence of the disease within family members. That's the idea of doing family risk studies in complex diseases; eosinophilic diseases are very complex.   [4:44] Dr. Peterson explains how she conducts a family risk study in Utah. The Utah Population Database is very helpful. The University of Utah has partnered with The Church of Jesus Christ of Latter-day Saints for large genealogical pedigrees that allow tracking disease through expanded pedigrees, with privacy and security limitations.   [5:24] It's necessary to clarify physician coding to make sure it's realistic and coded appropriately so that results are believable. It's very hard to recruit family members. Dr. Peterson feels extremely blessed to live in that area. The families are generous and giving. She also believes all eosinophilic families are generous.   [6:34] The farther out you can identify the risk for disease, the more likely you will find a common gene that could be implicated in disease risk or onset. If the disease is tracked in extended relatives, it implies a shared gene more than a shared environmental risk. If the disease is isolated within nuclear families, it may indicate an environmental risk.   [7:39] In doing familial research, Dr. Peterson is trying to develop a risk score. People are getting pretty good at diagnosing EoE, but Dr. Peterson would not say that the non-EoE EGIDs are well-established or well-diagnosed. They are missed commonly and often. To have a risk score from the extent of the disease in a family is helpful.    [8:12] Dr. Peterson notes that studies of cancer risk in extended families have established cancer risk scores and related screening that is needed.   [8:43] Dr. Peterson coauthored a paper in November 2020 about the familial risk of EoE, published in the Clinical Gastroenterology and Hepatology Journal. She and her colleagues looked at nuclear families. They were looking for how many members of the nuclear family of an EoE patient have esophageal eosinophilia. [9:28] They used a questionnaire on allergies, food allergies, and symptoms. They pulled in around 70 first-degree family members and scoped them for eosinophilia, pulled the records on the rest of the family members if they had been scoped, and assessed the risk for eosinophilia.   [9:51] Including the records, and assuming that everyone who hadn't had an endoscopy was negative, they found the risk for esophageal eosinophilia in first-degree family members was 14%, bordering on the familial risk for celiac disease. It's probably higher since they assumed anyone who hadn't been scoped didn't have eosinophilia.   [10:19] They called it esophageal eosinophilia, because the guidelines for diagnosing EoE suggest that the patient must complain of symptoms, and these family members did not have symptoms. It was interesting to find this high prevalence of eosinophilia in the nuclear family members of EoE patients. They had a higher risk of allergy, as well.   [11:14] Dr. Peterson explains the differences between esophageal eosinophilia and eosinophilic esophagitis (EoE). Esophageal eosinophilia means eosinophils are in the esophagus, >15 per high-power field in a biopsy. That could qualify as EoE when you go through the criteria of symptoms.   [12:19] We call it esophageal eosinophilia while we rule out everything else that could cause that cell to get recruited into the esophagus. It could be an allergic reaction to a medication, larger eosinophilic disorders, or parasitic infections. Esophageal eosinophilia means you had that initial biopsy that puts you at risk for EoE.   [13:06] You have to go down the diagnostic steps: Do I have symptoms? Do I have anything else that explains it? If you have nothing else that explains the eosinophils, and you have esophageal dysfunction, then you can call it EoE.   [13:33] Dr. Peterson, speaking personally, believes that educating doctors to ask patients about EoE symptoms would be useful in diagnosing EoE. People cope. You don't want to focus on your symptoms because you want to be able to focus on your life. If symptoms aren't brought to a doctor's attention, a diagnosis can get missed.   [16:47] Dr. Peterson discusses risks for EoE in families where allergies are present. Dr. Peterson is involved currently in another familial study to find more information about the risk of EoE where there are allergies in a family. In the preliminary data, it looks like there is a link with asthma. Asthma and EoE in a family seem to track together.   [17:31] The risk of EoE seems to be higher with additional allergies within a family. Dr. Peterson says they are cleaning up the data to get a better answer. It appears that allergies in general go along with some of the genes that have been identified in EoE. Watch for Dr. Peterson's papers going forward!   [19:05] They looked at around 300 eosinophilic gastroenteritis (EGE) patients and about 170 eosinophilic colitis (EoC) patients. If you have a proband with EoE, is there a higher family risk of having EGE or EoC? It looks like EoE puts you at higher risk of these other conditions. But with such low numbers in the study, the jury is still out.   [20:37] They looked at EGE codes because there is a subset of patients who have eosinophilic disease in their stomach and small bowel who don't have EoE. They found that in patients who have eosinophilic disease in the stomach or the small bowel, EoE is still commonly seen throughout families. EoE seems to be a common theme.   [21:54] Down the road, Dr. Peterson hopes to be able to identify enough families that they might be able to start looking at genes that might put people at risk for more extensive disease.   [23:07] Dr. Peterson discusses the difficulty in diagnosing eosinophilic colitis, inflammatory bowel disorder, and other disorders. Having eosinophils does not categorize you as an EGID patient. There are other disorders where eosinophils are present. We need a better understanding of eosinophilic colitis.   [25:21] Eosinophilic asthma and eosinophilic fasciitis are disorders that Dr. Peterson has not studied but are in the Institutional Review Board approved documentation for future study.   [26:18] Dr. Peterson addresses whether your degree of risk for an EGID increases if you have an immediate family member with an EGID, vs. a second cousin with an EGID. She would say yes, based on the hazard ratios in the data and knowing that eosinophilic disorders are complex and twin studies show an environmental influence.   [27:28] Dr. Peterson asks patients about their family history, especially when they have other symptoms besides EoE. It makes her more aware of what to test.   [29:10] A paper Dr. Peterson is about to submit studied family members who weren't affected, who were siblings of probands. Their mucosa wasn't entirely normal. They may be pre-diagnostic. These are patients who need to be followed. There may be things that set people up for the development of this disease, in the right environment.   [31:04] Something fascinating from the familial study is the challenge of diagnosing EGIDs. Fifty percent of the people they brought in hadn't had an endoscopy. We need to be proactive in identifying diseases in patients. In the study, there are a lot of general GI symptoms coded that Dr. Peterson wonders if they may be missed EGIDs.   [32:34] The NIH gave Dr. Peterson's team funding and they were able to do linkage analysis on several de-identified families that were at high risk for EGIDs. It looks like multiple genes have the potential to be involved. Personalizing medicine would be applicable if there were just one specific gene involved.   [33:23] Down the road, we may find some genes that portend higher risk and other genes that portend risk where we can do preventative environmental care. We can develop risk scores to identify risks and point to interventions.   [34:10] Mary Jo thanks Dr. Peterson for joining us today to share her expertise and help us learn and understand.   [34:36] Future research needs to be done where we are able to recruit patients and do more work looking at genetic linkage and get to the point where we can diagnose and identify non-EoE EGIDs well enough to explore them more, including eosinophilic colitis. Defining those diseases is necessary and needed.   [35:16] A lot of what Dr. Peterson is trying to do is to look further into combined diseases and hypereosinophilic states to determine if there is some gene within families that may help her to develop other therapies not focusing only on the GI tract but on a global approach to health for these patients.   [35:48] There is current research being done to find less invasive ways of identifying disease, such as imaging, so people don't have to undergo endoscopy. That research is being done on the commercial side.   [36:44] Dr. Peterson has been looking at food-specific antibodies. Also, research by other doctors is being done to identify other markers of the foods that often trigger the disease. There has been some interesting preliminary data. This can help patients to eliminate fewer foods.   [37:27] Dr. Peterson has been looking at less invasive ways to identify non-EoE EGIDs in ways that can avoid biopsy.   [38:04] What's being done to study Barrett's esophagus? Dr. Peterson speaks of past and planned research, using the Utah population database. They looked at the risk for Barrett's esophagus in patients with EoE and it was eight times higher than the normal population. Dr. Peterson correlates risks with reflux for Barrett's and EoE.   [39:26] There are still questions about which comes first, EoE, Barret's esophagus, or reflux. She also talks about the relationship between achalasia, allergic diseases, and EoE.   [41:05] To learn more about Dr. Peterson's research, please see the links in the show notes. To learn more about eosinophilic gastrointestinal disorders, please visit apfed.org/egids.   [41:29] To find a specialist, visit apfed.org/specialists. To connect with others impacted by eosinophilic diseases, please join APFED's online community on the Inspire Network at apfed.org/connections.   [41:48] Ryan and Mary Jo thank Dr. Kathryn Peterson again for joining them. Mary Jo thanks APFED's education partners, linked below, for supporting this episode.   Mentioned in This Episode: Kathryn A. Peterson, M.D. Pubmed.ncbi.nlm.nih.gov/36148824/ (to release February 2024) Pubmed.ncbi.nlm.nih.gov/33221551/ (published November 2020) University of Utah Health American Partnership for Eosinophilic Disorders (APFED) APFED on YouTube, Twitter, Facebook, Pinterest, Instagram Real Talk: Eosinophilic Diseases Podcast   Education Partners: This episode of APFED's podcast is brought to you thanks to the support of AstraZeneca, Bristol Myers Squibb, Sanofi, and Regeneron.   Tweetables:   “When we study familial risk, we're looking at the risk of the disease in a patient when a family member is affected, compared to the general population.” — Dr. Kathryn Peterson   “I think allergies, in general, kind of go along with some of the genes that have been identified in EoE.” — Dr. Kathryn Peterson   “Fifty percent of the people we brought in [to this familial risk study] hadn't had an endoscopy. We need to be proactive in identifying diseases in patients.” — Dr. Kathryn Peterson   About Dr. Kathryn Peterson Kathryn Peterson, MD is a Professor of Gastroenterology at the University of Utah Health. She is certified by the American Board of Internal Medicine.   Dr. Peterson specializes in diagnosing and treating diseases of the digestive system including eosinophilic esophagitis, Barrett's esophagus, and inflammatory bowel disease. She completed her medical degree at the University of Texas Southwestern, followed by residency and a fellowship at the University of Utah and a master's program in Epidemiology at Harvard University.   Bio: Healthcare.utah.edu/find-a-doctor/kathryn-peterson    .  

Esophageal versus Rectal Temperature Monitoring during Whole-body Therapeutic Hypothermia for Hypoxic-ischemic Encephalopathy: Association with Short and Long-term Outcomes. Wu TW, Schmicker R, Wood TR, Mietzsch U, Comstock B, Heagerty PJ, Rao R, Gonzalez F, Juul S, Wu YW.J Pediatr. 2024 Feb 1:113933. doi: 10.1016/j.jpeds.2024.113933. Online ahead of print.PMID: 38309524 Free article. As always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below. Enjoy!

Hello Friends, We have a new episode of journal club for you this week. On this episode Ben & Daphna review the latest research in neonatology, and welcome the EBNEO team for a new commentary. The articles reviewed this week include: Esophageal versus Rectal Temperature Monitoring during Whole-body Therapeutic Hypothermia for Hypoxic-ischemic Encephalopathy: Association with Short and Long-term Outcomes. Wu TW, Schmicker R, Wood TR, Mietzsch U, Comstock B, Heagerty PJ, Rao R, Gonzalez F, Juul S, Wu YW.J Pediatr. 2024 Feb 1:113933. doi: 10.1016/j.jpeds.2024.113933. Online ahead of print.PMID: 38309524 Free article.Neonatal Outcomes After COVID-19 Vaccination in Pregnancy. Norman M, Magnus MC, Söderling J, Juliusson PB, Navér L, Örtqvist AK, Håberg S, Stephansson O.JAMA. 2024 Feb 6;331(5):396-407. doi: 10.1001/jama.2023.26945.PMID: 38319332Maternal syphilis rates tripled in the US between 2016 and 2022, data show. Tanne JH.BMJ. 2024 Feb 15;384:q416. doi: 10.1136/bmj.q416.PMID: 38359912 No abstract available. Therapeutic hypothermia for preterm infants 34-35 weeks gestational age with neonatal encephalopathy. Kim SH, El-Shibiny H, Inder T, El-Dib M.J Perinatol. 2024 Jan 16. doi: 10.1038/s41372-024-01874-x. Online ahead of print.PMID: 38228763Randomised study of a new inline respiratory function monitor (Juno) to improve mask seal and delivered ventilation with neonatal manikins. Tracy MB, Hinder M, Morakeas S, Lowe K, Priyadarshi A, Crott M, Boustred M, Culcer M.Arch Dis Child Fetal Neonatal Ed. 2024 Feb 9:fetalneonatal-2023-326256. doi: 10.1136/archdischild-2023-326256. Online ahead of print.PMID: 38336472Dextrose gel prophylaxis for neonatal hypoglycaemia and neurocognitive function at early school age: a randomised dosage trial. Wei X, Franke N, Alsweiler JM, Brown GTL, Gamble GD, McNeill A, Rogers J, Thompson B, Turuwhenua J, Wouldes TA, Harding JE, McKinlay CJD; pre-hPOD Early School-age Outcomes Study Group.Arch Dis Child Fetal Neonatal Ed. 2024 Feb 12:fetalneonatal-2023-326452. doi: 10.1136/archdischild-2023-326452. Online ahead of print.PMID: 38307710Effect of human milk-based fortification in extremely preterm infants fed exclusively with breast milk: a randomised controlled trial. Jensen, G. B., Domellöf, M., Ahlsson, F., Elfvin, A., Navér, L., & Abrahamsson, T. eClinicalMedicine (2023).Neurodevelopmental Outcomes of Extremely Preterm Infants Fed Donor Milk or Preterm Infant Formula: A Randomized Clinical Trial. Colaizy TT, Poindexter BB, McDonald SA, et al. JAMA. 2024;331(7):582–591. doi:10.1001/jama.2023.27693EBNEO Commentary: De-MIST-ifying the 2-year outcomes of non-invasive surfactant therapy. Loft L, Ferguson KN, Tingay DG. Acta Paediatr. 2024 Jan 25. doi: 10.1111/apa.17116. O As always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below. Enjoy!

Review of esophageal fluoroscopy for radiology board exams, part 2. Check out the free study guide available for download at www.theradiologyreview.com. Prepare to succeed!

Review of esophageal fluoroscopy (part 1) for Radiology board review.  Remember to check out the free downloadable study guide at www.theradiologyreview.com.  Prepare to succeed!

1/6/24 - Host Doug Stephan and Dr. Ken Kronhaus of Lake Cardiology (352-735-1400) cover a number of topics, Including: 7 healthy New Years Resolutions, Dr. Ken explains Lp(a) and why you need to have yours checked with your next blood work, 20% of adults have inherited Lp(a) genetically, salt's effects on your Kidneys, the best substitutes for salt, "Tummy Tucks" have been determined to be safe and reliable, giving up alcohol completely could help prevent Oral or Esophageal Cancer, there is a new pill for Postpartum Depression, why you should consider the latest COVID vaccination.

In this special podcast Dr Rita Knotts, with the Center for Esophageal Health at NYU-Langone, and Dr Elizabeth Volkmann, founder and codirector of the UCLA Connective Tissue Disease-Related Interstitial Lung Disease, discuss the intersection of their specialities in the care of patients with scleroderma, interstitial lung disease, and esophageal conditions such as reflux.

This week it's Annie and Reid on the mic to talk everything going on in the Bravoverse! In That's My Opinion (9:00) they get into the brand new Vanderpump Rules Season 11 and The Traitors U.S. Season 2 trailers, PLUS their quick initial reactions to Real Housewives: Ultimate Girls Trip - RHONY Legacy on Peacock! Then they dive into all the recaps you love: First with Real Housewives of Salt Lake City on their Bermuda cast trip (25:02); the Real Housewives of Beverly Hills as they celebrate Sutton's store's anniversary (54:46); the Real Housewives of Miami on their Palm Beach cast trip (1:14:00); and the Real Housewives of Potomac on their Austin cast trip (1:25:06). Stay tuned for a couple of bonus episodes while we take some time off for the holidays! We'll see you in a couple of weeks. Thanks for supporting our show! Support the showConnect with us: https://linktr.ee/Aboutbravo06

Jane has a giant button going down her esophageal passage, and Fi is less than impressed. Once they get over that, they're talking your most recent pet photos, whether women from history drive, and they have a big political prediction for Suella Braverman's next career move... Lee Child is our big guest today. The Secret, written in collaboration with his brother Andrew, is out now. If you want to contact the show to ask a question and get involved in the conversation then please email us: janeandfi@times.radio Follow us on Instagram! @janeandfi Assistant Producer: Megan McElroy Times Radio Producer: Rosie Cutler Hosted on Acast. See acast.com/privacy for more information.

In this episode, hosts Drs. Jennifer Lee and Jason Silverman talk to Dr. Christophe Faure about tracheoesophageal fistula and esophageal atresia. This important congenital abnormality carries a host of potential future health implications that are important to understand and manage. Dr. Faure is a Professor of Pediatrics at Universite de Montreal and a pediatric gastroenterologist at CHU Ste-Justine.  He is also the director of the Esophageal Atresia Clinic at Ste-Justine and runs a basic research lab focused on discovering the mechanisms behind EA and studying new treatments based on tissue engineering. This episode is eligible for CME credit!  Once you have listened to the episode, click this link to claim your credit.  Credit is available to NASPGHAN members (if you are not a member, you should probably sign up).  And thank you to the NASPGHAN Professional Education Committee for their review!Important links:International Network of Esophageal Atresia (a non-profit organization of professionals working in the field of Esophageal atresia)Publications mentioned on this episode (and more!)Learning Objectives:Understand the complications commonly experienced by children with esophageal atresia.Outline the recommended management of gastroesophageal reflux in children with esophageal atresia.Understand the role of the multidisciplinary team in the long-term surveillance and health maintenance of children with esophageal atresia.Produced by: Jason SilvermanSupport the showMerch websiteAs always, the discussion, views, and recommendations in this podcast are the sole responsibility of the hosts and guests and are subject to change over time with advances in the field.Follow us on Twitter, Facebook and Instagram for all the latest news and upcoming episodes!Support the showAs always, the discussion, views, and recommendations in this podcast are the sole responsibility of the hosts and guests and are subject to change over time with advances in the field.Follow us on Twitter, Facebook and Instagram for all the latest news and upcoming episodes!

In the June episode of Critical Decisions in Emergency Medicine, Drs. Danya Khoujah and Wendy Chang discuss pericarditis presentations in the emergency department and esophageal emergencies. As always, you'll hear about the hot topics covered in CDEM's regular features, including lead reversals in The Critical ECG, Meckel diverticulum in Clinical Pediatrics, trans-scaphoid perilunate and complete radiocarpal dislocations in Critical Cases in Orthopedics and Trauma, drainage of an acute paronychial abscess in The Critical Procedure, recurrent, low-risk chest pain in the LLSA Literature Review, an elbow injury in a child in The Critical Image, off-label tizanidine use in the Drug Box, and pyrethroid toxicity in the Tox Box.

Liz Eidelman, whose name some of you may recognize as the funny mom on Instagram @lizeidelman, gave birth to her first child in the hospital with a team of med students present. She had an episiotomy she didn't want, a vacuum-assist that led to another flood of people in the room, and a baby who was whisked away to the NICU within moments of birth, leaving Liz in the dark about her baby's condition. Overhearing nurses whisper, "The mother doesn't know yet," added to her anxiety. What Liz and her husband soon learned was that their baby was born with esophageal atresia, necessitating a life-saving surgery on Day Two of their baby's life.Now, with the perspective of a few years and two births under her belt, Liz reflects on the many ways in which she was grossly mistreated in her birth, by the very people and system who helped her baby go from a status of "born incompatible with life" to healthy and well. Liz dives into how her labor could have taken a different course, not only the first time but also the second, had she been more aware of her rights within the hospital birth environment. Liz shares her personal story and reveals alarming details that ignited her passion to become a doula. She also created a thriving Instagram community for moms, where humor serves as the antidote for the challenges of parenting, birth, and life. Don't miss this enlightening and empowering episode with Liz Eidelman.Liz on Instagram**********Down to Birth is sponsored by:Needed -- Optimal nutritional products to nourish yourself before, during, and after pregnancy DrinkLMNT -- Purchase LMNT today and receive a free sample kit. Stay salty.Love Majka Products -- Support your milk supply with nourishing protein powder, hydration boosters and lactation bites.Silverette Nursing Cups -- Soothe and heal sore nipples with 925 silver nursing cups.Postpartum Soothe -- Herbs and padsicles to heal and comfort after vaginal birth.  Connect with us on Patreon for our exclusive content.Email Contact@DownToBirthShow.comInstagram @downtobirthshowCall us at 802-GET-DOWN Work with Cynthia: 203-952-7299 HypnoBirthingCT.com Work with Trisha: 734-649-6294 Please remember we don't provide medical advice. Speak to your licensed medical provider for all your healthcare matters.

Hello Friends! It is time for the September Q&A episode! Today, we open with two listener emails sharing their experiences on declining circumcision and accepting a necessary emergency cesarean birth. Next, we dive into your questions beginning with:Can I still labor and birth in the tub even if my membranes have ruptured before labor begins? Lucky for ya'll, we have Barbara Harper of Waterbirth International pop on the show to answer this question.Next up, we address whether experiencing a 3rd or 4th-degree tear during your first birth should deter you from pursuing a subsequent vaginal birth. Does it categorize you as high risk? We'll explore this important topic.Seeking more comprehensive solutions for infant reflux beyond the basics? We've got you covered.Then, we tackle the dilemma of giving birth at home when it feels safest, despite not feeling the most relaxed due to working from home. We'll share valuable perspectives on making the right choice for you.Curious about the accuracy of ultrasounds in diagnosing esophageal atresia?  Liz Eidelman, a mother of a baby born with EA, joins us to answer this question. And that's just the tip of the iceberg! In our extended version of this episode, available exclusively on Patreon and Apple subscriptions (ad-free, of course), we delve into a treasure trove of topics, including ABO incompatibility and jaundice, alternatives to ibuprofen for postpartum cramping, the newborn transition, nuchal cords at birth, and much more!As always, we close with quickies and a personal question about the best advice each of us has ever received. PS: Don't miss the outtake at the end of every episode. **********Down to Birth is sponsored by:Needed -- Optimal nutritional products for before, during and after pregnancyModern Nursery--Your one-stop shop for eco-friendly, stylish baby gearDrinkLMNT -- Purchase LMNT today and receive a free sample kit.Love Majka Products -- Support your milk supply.Silverette Nursing Cups -- Soothe and heal sore nipples with 925 silver nursing cups.Postpartum Soothe -- Herbs and padsicles to heal and comfort. Connect with us on Patreon for our exclusive content.Email Contact@DownToBirthShow.comInstagram @downtobirthshowCall us at 802-GET-DOWN Work with Cynthia: 203-952-7299 HypnoBirthingCT.com Work with Trisha: 734-649-6294 Please remember we don't provide medical advice. Speak to your licensed medical provider for all your healthcare matters.

So a patient walks into a fluoroscopy suite, points to their throat, and says “I have trouble swallowing.” You do the VFSS, and their oropharynx looks…okay! Maybe even within normal limits! Now what? *The esophagus has entered the chat* In this podcast episode, Theresa Richard interviews Dr. Watts, a speech-language pathologist, researcher, and clinician scientist at the University of South Florida known for her work with esophageal dysphagia.  Get the show notes: https://syppodcast.com/293 The passion for esophageal dysphagia [00:02:19] The development of the REST protocol [00:03:30] Future research and expansion of the REST protocol [00:06:06] The nature of modified barium swallow [00:10:17] Screening protocol and next steps [00:11:23] Importance of multidisciplinary team [00:13:58] The implementation of esophageal dysphagia education [00:19:58] The prevalence of esophageal dysphagia and the need for further investigation [00:20:59] The importance of counseling and referrals in dysphagia management [00:23:06] The Art and Science of Fluoroscopy [00:29:04] Standardized Protocol for Reporting Results [00:30:18] Describing Aberrant Movement and Reporting Failed Screening [00:31:19] The post 293 – The Esophagus Has Entered the Chat: Understanding and Addressing Esophageal Dysphagia with Dr. Watts appeared first on Swallow Your Pride Podcast.

Disorders of the esophagus are fairly straightforward, but there are quite a few and they can be difficult to keep straight. Packed with lots of quiz questions for a relaxing yet engaging review, this episode is just the ticket to organize these various conditions in your brain. Our newest team member MS3 Kate Spencer will drill these disorders into your memory!

In this episode, our team discusses the Checkmate 577 trial, the landmark paper which approved the use of nivolumab for adjuvant treatment of stage II & III esophageal & GE junction cancer. Listen as our team reviews the study population, methods and results of this trial & discusses its clinical application as well as potential areas of future research. Learning Objectives: -Review the staging and treatment of esophageal and GEJ cancer -Discuss the population, methods, and results of the Checkmate 577 trial -Understand the mechanism of action of nivolumab and the PD1 pathway -Discuss the implications of the Checkmate 577 trial in clinical practice and areas of future research Hosts: Kelly Daus MD, Megan Lenihan MD, Peter White MD, and Brian Louie MD Referenced Material https://www.nejm.org/doi/full/10.1056/NEJMoa2032125 Kelly RJ, Ajani JA, Kuzdzal J, et al. Adjuvant nivolumab in resected esophageal or gastroesophageal junction cancer. N Engl J Med. 2021;384(13):1191-1203. doi:10.1056/NEJMoa2032125 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7136921/ Han Y, Liu D, Li L. PD-1/PD-L1 pathway: current researches in cancer. Am J Cancer Res. 2020 Mar 1;10(3):727-742. PMID: 32266087; PMCID: PMC7136921. Ad referenced in episode: A team at the Brooke Army Medical Center is working to better define proficiency-based metrics for competency in commonly performed robotic general surgery procedures. If you are a general surgery resident or practicing surgeon who performs robotic assisted cholecystectomies or inguinal hernia repairs,  reach out to the PI, Robert Laverty, MD, at rblaverty@gmail.com for more information on how you could be compensated $500 per video submitted of each (up to $1000 per surgeon). Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.   If you liked this episode, check out other thoracic surgery episodes here https://behindtheknife.org/podcast-category/cardiothoracic/

In April of 2022, a 38-year-old man died in his apartment due to an apparent medical condition. Without seeing the scene of his death, his parents had him cremated, fully believing the ruling. But later, when his ex-girlfriend entered the apartment to a horrific, bloody mess, his friends and family began to doubt his cause of death. And after seeing damning security footage and audio from his neighbor, they knew: he had been murdered. This is the story of Johnny Cashman. BONUS EPISODES patreon.com/goingwestpodcast CASE SOURCES 1. Arrin Stoner: https://www.youtube.com/watch?v=Kv2J7WmpaSA 2. WSET: https://wset.com/news/local/johnny-cashman-death-investigation-police-negligence-steven-church-elizabethton-tennessee-gruesome-scene-family-questioning-lynchburg-police-department-murder-medical-emergency-bloody-crime-scene-surveillance-video-virginia-april-2022 3. WSET: https://wset.com/news/local/police-find-speak-with-witness-in-investigation-of-man-found-dead-in-lynchburg-apartment 4. Web Sleuths: https://www.websleuths.com/forums/threads/va-johnny-cashman-jr-38-death-investigation-lynchburg-apr-2022.636773/ 5. Village Soup: https://waldo.villagesoup.com/2014/07/08/july-4-fight-ends-with-stitches-jail-time-for-belfast-man-1208648/ 6. Pen Bay Pilot: https://www.penbaypilot.com/article/belfast-police-department-beat-shoplifting-insurance-violations/26011 7. Sara's LinkedIn: https://www.linkedin.com/in/sara-cashman-a9a289b4/ 8. Howard Cashman Obituary: https://obituaries.eagletribune.com/obituary/howard-cashman-771016101 9. Spokeo: https://www.spokeo.com/John-Cashman/Maine/Lincolnville/p356432521 10. Medical Examiner's Report: https://www.scribd.com/document/574955166/Johnny-Cashman-Medical-Examiner-s-Report 11. Lynchburg VA Police: https://www.lynchburgvapolice.gov/news-updates/update-2-attempt-to-identify-witness/ 12. WSET: https://wset.com/news/local/commonwealths-attorney-announces-no-charges-in-death-of-john-cashman 13. Mayo Clinic: https://www.mayoclinic.org/diseases-conditions/esophageal-varices/symptoms-causes/syc-20351538#:~:text=Esophageal%20varices%20are%20enlarged%20veins,throat%20and%20stomach%20(esophagus). Learn more about your ad choices. Visit podcastchoices.com/adchoices